Overview

Safety of Ascending Doses of Niclosamide (UNI911 INHALATION) in Healthy Volunteers

Status:
Completed
Trial end date:
2020-12-04
Target enrollment:
Participant gender:
Summary
This is a Phase 1 Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess the Safety of Ascending Doses of UNI911 INHALATION in Healthy Volunteers in Preparation for Evaluation in Adults with COVID-19
Phase:
Phase 1
Details
Lead Sponsor:
UNION therapeutics